Search - tctmd.com

Displaying 421 - 440 of 479

Sort: Relevancy | Date

Presentation

A Prospective Multicenter Trial Comparing Paclitaxel-Coated Balloon Angioplasty with Uncoated Balloon Angioplasty in DES Restenosis

Presenter: Harald Rittger

February 28, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

Presentation

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Presenter: G. Maluenda

February 15, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Presentation

Lower Risk of ST and Restenosis with Unrestricted Use of ‘New-Generation’ DES

Presenter: G. Sarno

January 08, 2012

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

Presentation TCT 2012

The Difference of Predictors for Occurrence of Instent Restenosis in the under-expanded or non under-expanded post-DES implantation : An intravascular ultrasound analysis...

Presenter: Ki-Woon Kang, Byeong-Keuk Kim, Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

January 03, 2012

Presentation TCT 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presenter: Didier Carri?, Nicolas Delarche, Christophe Piot, Jacques Berland, Nicolas Meneveau, Laurent Benello, Antoine Py, Emmanuel Teiger, Laurent Leborgne, Gilles Bayet, Olivier Wittenberg

January 03, 2012

Presentation TCT 2012

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

Presenter: Torsten Schwalm, J?rg Carlsson, Bo Lagerqvist, Stefan James

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Conference News

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

November 16, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

Advertisement

A Prospective Multicenter Trial Comparing Paclitaxel-Coated Balloon Angioplasty with Uncoated Balloon Angioplasty in DES Restenosis

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

SCAAR: Second-Generation DES Improve Hard Outcomes

Lower Risk of ST and Restenosis with Unrestricted Use of ‘New-Generation’ DES

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

The Difference of Predictors for Occurrence of Instent Restenosis in the under-expanded or non under-expanded post-DES implantation : An intravascular ultrasound analysis...

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR)

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Some New-Generation Stents Prone to Longitudinal Distortion

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

PRISM Individualized Informed Consent Improves PCI Choice, Experience

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content